BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rossi T, Tedaldi G, Petracci E, Abou Khouzam R, Ranzani GN, Morgagni P, Saragoni L, Monti M, Calistri D, Ulivi P, Molinari C. E-cadherin Downregulation and microRNAs in Sporadic Intestinal-Type Gastric Cancer. Int J Mol Sci 2019;20:E4452. [PMID: 31509966 DOI: 10.3390/ijms20184452] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Yue Y, Lin X, Qiu X, Yang L, Wang R. The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer. Front Cell Dev Biol 2021;9:802745. [PMID: 34966746 DOI: 10.3389/fcell.2021.802745] [Reference Citation Analysis]
2 Nowak E, Bednarek I. Aspects of the Epigenetic Regulation of EMT Related to Cancer Metastasis. Cells 2021;10:3435. [PMID: 34943943 DOI: 10.3390/cells10123435] [Reference Citation Analysis]
3 Piccolo G, Zanghì A, Di Vita M, Bisagni P, Lecchi F, Cavallaro A, Cardì F, Lo Menzo E, Cappellani A. The role of E-cadherin expression in the treatment of western undifferentiated early gastric cancer: Can a biological factor predict lymph node metastasis? PLoS One 2020;15:e0232429. [PMID: 32348353 DOI: 10.1371/journal.pone.0232429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zeng W, Zhang S, Yang L, Wei W, Gao J, Guo N, Wu F. Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer. BMC Med Genet 2020;21:28. [PMID: 32041551 DOI: 10.1186/s12881-020-0967-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
5 Syllaios A, Sakellariou S, Garmpis N, Sarlani E, Damaskos C, Apostolou K, Kykalos S, Gazouli M, Karavokyros I, Schizas D. The role of miR-101 in esophageal and gastric cancer. Per Med 2021;18:491-9. [PMID: 34402321 DOI: 10.2217/pme-2021-0024] [Reference Citation Analysis]
6 Kaszak I, Witkowska-Piłaszewicz O, Niewiadomska Z, Dworecka-Kaszak B, Ngosa Toka F, Jurka P. Role of Cadherins in Cancer-A Review. Int J Mol Sci 2020;21:E7624. [PMID: 33076339 DOI: 10.3390/ijms21207624] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
7 Tedaldi G, Molinari C, São José C, Barbosa-Matos R, André A, Danesi R, Arcangeli V, Ravegnani M, Saragoni L, Morgagni P, Rebuzzi F, Canale M, Pignatta S, Ferracci E, Martinelli G, Ranzani GN, Oliveira C, Calistri D, Ulivi P. Genetic and Epigenetic Alterations of CDH1 Regulatory Regions in Hereditary and Sporadic Gastric Cancer. Pharmaceuticals (Basel) 2021;14:457. [PMID: 34066170 DOI: 10.3390/ph14050457] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Han XL, Yi CL, Ma JD, He Y, Wu LM, Wang YF, Yang HJ, Liang DY, Shi JF. Clinical Value of Pepsinogen in the Screening, Prevention, and Diagnosis of Gastric Cancer. Lab Med 2021:lmab035. [PMID: 34508270 DOI: 10.1093/labmed/lmab035] [Reference Citation Analysis]
9 Gharbi S, Mohammadi Z, Dezaki MS, Dokanehiifard S, Dabiri S, Korsching E. Characterization of the first microRNA in human CDH1 that affects cell cycle and apoptosis and indicates breast cancers progression. J Cell Biochem 2022. [PMID: 34997630 DOI: 10.1002/jcb.30211] [Reference Citation Analysis]